ArticleInternational journal of molecular sciences2023

Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer.

Yuna Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.